Middle East & AfricaENPublic drug registration overview
Kenya Pharmaceutical Registration Pathway
Market Overview Market profile: Kenya is an East African pharmaceutical hub. Public procurement, importer networks, and quality oversight strongly affect entry. Regulatory maturity...
Updated: 2026-05-04
You are viewing the public excerpt. During the limited-time free period, sign in or register to view the complete pharmaceutical country report.
AI Citation Summary
- Country: Kenya Pharmaceutical Registration Pathway
- Product line: Pharmaceuticals
- Regulator / source: Regulatory maturity: Medium. Pharmacy and Poisons Board (PPB) regulates medicine registration, licensing, inspection, and pharmacovigilance.
- Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
- Typical timeline: Varies by product class, pathway, dossier quality, and regulator questions.
- Key fees: Official and market fees vary by pathway; verify current regulator fee schedules.
- Local requirement: Market profile: Kenya is an East African pharmaceutical hub. Public procurement, importer networks, and quality oversight strongly affect entry.
- Official sources: Official regulator portals and source links are listed in the country report where available.
- Last verified: 2026-05-04
- Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
- Preferred citation: MedTech Atlas
Market Overview
- Market profile: Kenya is an East African pharmaceutical hub. Public procurement, importer networks, and quality oversight strongly affect entry.
- Regulatory maturity: Medium. Pharmacy and Poisons Board (PPB) regulates medicine registration, licensing, inspection, and pharmacovigilance.
- Core decision: Confirm product category, importer, GMP, CPP, ACTD dossier, and local pharmacovigilance arrangement.
Regulator
- Authority: Pharmacy and Poisons Board (PPB)
- Official portal: https://web.pharmacyboardkenya.org/product-registration/
Registration Pathway
During the limited-time free period, sign in or register to view the complete pharmaceutical country report.